Contact
searchSearch
HMP Global

Prostate Cancer Topic Center

News
Genomic Classifier Validates Early Prostate Cancer Recurrence Risk in African American Men, VA Study Finds
12/23/2025
Grace Taylor, MS, MA
A prospective US Veterans Affairs multicenter study shows that a validated genomic classifier can independently predict early biochemical recurrence in African American men with localized prostate cancer, supporting its use to improve risk...
A prospective US Veterans Affairs multicenter study shows that a validated genomic classifier can independently predict early biochemical recurrence in African American men with localized prostate cancer, supporting its use to improve risk...
A prospective US Veterans...
12/23/2025
Veterans Health Today
News
PSMA PET Staging Shifts Initial Prostate Cancer Treatment Patterns in US Veterans
12/17/2025
Grace Taylor, MS, MA
Prostate-specific membrane antigen (PSMA) PET staging is rapidly altering prostate cancer care in US veterans, driving greater use of systemic therapy and fewer prostatectomies.
Prostate-specific membrane antigen (PSMA) PET staging is rapidly altering prostate cancer care in US veterans, driving greater use of systemic therapy and fewer prostatectomies.
Prostate-specific membrane...
12/17/2025
Veterans Health Today
News
Real-World VHA Data Show High Relugolix Adherence Across Races in Prostate Cancer
12/12/2025
Juliet Gallagher
New real-world evidence from the Veterans Health Administration—the largest integrated health care system in the US—provides insight into adherence and prostate-specific antigen (PSA) response patterns with relugolix, the only US Food and...
New real-world evidence from the Veterans Health Administration—the largest integrated health care system in the US—provides insight into adherence and prostate-specific antigen (PSA) response patterns with relugolix, the only US Food and...
New real-world evidence from the...
12/12/2025
Veterans Health Today
News
Prebiopsy Prostate MRI Use Rising in US Veterans but Key Gaps Persist
12/05/2025
Grace Taylor, MS, MA
Prebiopsy prostate MRI use is rising across the US Department of Veterans Affairs (VA), but new data reveal persistent racial and rural disparities that could impact veterans’ prostate cancer outcomes.
Prebiopsy prostate MRI use is rising across the US Department of Veterans Affairs (VA), but new data reveal persistent racial and rural disparities that could impact veterans’ prostate cancer outcomes.
Prebiopsy prostate MRI use is...
12/05/2025
Veterans Health Today
News
Androgen Deprivation Therapy Increases Cardiovascular and Bone Risks in Veterans With Prostate Cancer
11/25/2025
Juliet Gallagher
A large, nationwide cohort study published using Veterans Affairs Health Care System (VAHCS) data found that androgen deprivation therapy (ADT) for prostate cancer significantly increases cardiovascular and bone-related complications across...
A large, nationwide cohort study published using Veterans Affairs Health Care System (VAHCS) data found that androgen deprivation therapy (ADT) for prostate cancer significantly increases cardiovascular and bone-related complications across...
A large, nationwide cohort study...
11/25/2025
Veterans Health Today
News
Genetic Testing Rates Increasing Among Veterans With Metastatic Prostate Cancer
11/20/2025
Grace Taylor, MS, MA
A US Veteran’s Affairs (VA) study reveals that while hereditary cancer genetic testing among veterans with metastatic prostate cancer (mCRPC) has surged in recent years, overall utilization remains strikingly low despite expanding precision...
A US Veteran’s Affairs (VA) study reveals that while hereditary cancer genetic testing among veterans with metastatic prostate cancer (mCRPC) has surged in recent years, overall utilization remains strikingly low despite expanding precision...
A US Veteran’s Affairs (VA)...
11/20/2025
Veterans Health Today
News
Agent Orange Exposure Linked to Higher Prostate Cancer Risk, Mortality Among US Veterans
11/18/2025
Grace Taylor, MS, MA
A nationwide US Veterans Affairs (VA) study found that Vietnam veterans exposed to Agent Orange face significantly higher risks of prostate cancer, metastasis, and mortality than their unexposed peers.
A nationwide US Veterans Affairs (VA) study found that Vietnam veterans exposed to Agent Orange face significantly higher risks of prostate cancer, metastasis, and mortality than their unexposed peers.
A nationwide US Veterans Affairs...
11/18/2025
Veterans Health Today
News
PSMA PET Use Rapidly Expands for Prostate Cancer Staging in US Veterans
11/14/2025
Grace Taylor, MS, MA
Prostate-specific membrane antigen (PSMA) PET imaging has rapidly become a cornerstone of prostate cancer staging in US veterans, revealing high diagnostic value for advanced disease while prompting new questions about its role in...
Prostate-specific membrane antigen (PSMA) PET imaging has rapidly become a cornerstone of prostate cancer staging in US veterans, revealing high diagnostic value for advanced disease while prompting new questions about its role in...
Prostate-specific membrane...
11/14/2025
Veterans Health Today
News
Abiraterone and Enzalutamide Show Comparable Outcomes in US Veterans With Metastatic Prostate Cancer
11/05/2025
Juliet Gallagher
A large cohort study published by the US Veterans Affairs Health Care System found that abiraterone and enzalutamide provide similar clinical outcomes for patients with metastatic hormone-sensitive prostate cancer (mHSPC). Researchers...
A large cohort study published by the US Veterans Affairs Health Care System found that abiraterone and enzalutamide provide similar clinical outcomes for patients with metastatic hormone-sensitive prostate cancer (mHSPC). Researchers...
A large cohort study published...
11/05/2025
Veterans Health Today
News
Genetic Variation Linked to Poorer Outcomes After Radiation and ADT in Veterans With Prostate Cancer
10/30/2025
Grace Taylor, MS, MA
An analysis of the Million Veterans Program reveals that men with the adrenal-permissive HSD3B1 genotype face significantly poorer outcomes after radiation and androgen deprivation therapy for localized prostate cancer.
An analysis of the Million Veterans Program reveals that men with the adrenal-permissive HSD3B1 genotype face significantly poorer outcomes after radiation and androgen deprivation therapy for localized prostate cancer.
An analysis of the Million...
10/30/2025
Veterans Health Today
News
New VA Study Reveals Rising Burden of Advanced Prostate Cancer Among Veterans
10/23/2025
Juliet Gallagher
A recent study published in the Journal of the National Comprehensive Cancer Network offers the most comprehensive look to date at metastatic castration-resistant prostate cancer (mCRPC) among veterans, leveraging data from more than 1.1...
A recent study published in the Journal of the National Comprehensive Cancer Network offers the most comprehensive look to date at metastatic castration-resistant prostate cancer (mCRPC) among veterans, leveraging data from more than 1.1...
A recent study published in the...
10/23/2025
Veterans Health Today

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use